新冠疫苗接种信息偏好与接种地点:与疫苗犹豫及种族/族裔的关联
本研究通过在线调查( oversampling 黑人和拉丁裔成员)纳入1668名参与者,分析新冠疫苗接种信息偏好和接种地点偏好与接种意愿及种族/族裔的关联。疫苗犹豫者(对接种意愿回答「不确定」或「否」)更倾向于与医生交谈获取信息,且「不确定」者更偏好医生办公室接种,该偏好存在种族/族裔差异。
要点
- 疫苗犹豫者更倾向与医生交谈获取接种信息(25.0%和23.4% vs 7.8%,P<.001)。
- 「不确定」者中61.8%偏好医生办公室接种,显着高于「是」者的35.2%(P<.001)。
- 偏好地点因种族/族裔而异:黑人「不确定」者67.6%偏好医生办公室,拉丁裔60.2%,白人54.9%(P<.001)。
核心结论
- 疫苗犹豫者更倾向于通过医生交谈获取信息并偏好医生办公室接种,且该偏好存在种族/族裔差异,提示应将医疗提供者整合入新冠疫苗接种计划。
研究设计与样本
- 在线调查, oversampling 黑人和拉丁裔小组成员,共1668名参与者;女性占53.2%,白人34.8%,黑人33.3%,拉丁裔31.8%。
主要发现
- 疫苗犹豫者(回答「不确定」或「否」)比回答「是」者更可能偏好与医生交谈(25.0%和23.4% vs 7.8%,P<.001)。
- 回答「不确定」者中61.8%偏好医生办公室接种,回答「是」者中为35.2%(P<.001)。
- 偏好地点因种族/族裔而异(P<.001):黑人「不确定」者67.6%偏好医生办公室,拉丁裔60.2%,白人54.9%。
临床怎么用
- 针对疫苗犹豫人群,可优先通过医生面对面沟通提供接种信息,并在医生办公室设置接种点以提高接种意愿。
- 接种服务规划应考虑种族/族裔差异,针对黑人、拉丁裔等群体优化医生办公室接种的可及性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study examined the association between preferences for being informed about the COVID-19 vaccine and where to receive it with vaccination intent and race/ethnicity. We conducted an online survey, oversampling Black and Latino panel members. The 1668 participants were 53.2% female, 34.8% White, 33.3% Black, and 31.8% Latino. Participants who were vaccine hesitant (answered "not sure" or "no" to vaccination intent) were more likely to prefer a conversation with their doctor compared to those who answered "yes" (25.0% and 23.4% vs 7.8%, P < .001, respectively). Among participants who responded "not sure", 61.8% prefer to be vaccinated at a doctor's office, compared with 35.2% of those who responded "yes" (P < .001). Preferred location differed by race/ethnicity (P < .001) with 67.6% of Black "not sure" participants preferring a doctor's office compared to 60.2% of Latino and 54.9% of White "not sure" participants. These findings underscore the need to integrate healthcare providers into COVID-19 vaccination programs.
引用
- Fisher KA, Nguyen N, Crawford S, et al. Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity. Vaccine. 2021. PMID: 34629210. doi:10.1016/j.vaccine.2021.09.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。